Recerca, Chagas

ChagasLAMP (GHIT G2020-203)

Field validation of Trypanosoma cruzi-LAMP: a molecular point-of-care test for the control of congenital Chagas disease

A young Bolivian girl is tested for Chagas disease
Foto: Ana Ferreira
Durada
01/04/2021 - 31/03/2023
Coordinador
Julio Alonso
Finançadors
Global Health Innovative Fund (GHIT)

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects ~7 million people, mostly in Latin America. Vector-borne transmission is on the way of being controlled in several countries, but vertical transmission remains an uncontrolled major public-health challenge. Remarkably, available drugs have a very high cure rate in T. cruzi-infected newborns if administered early upon infection, thus a timely diagnose is crucial for treatment success.

However, the algorithm to detect congenital T. cruzi infection involves parasitological methods that lack sensitivity and a serological study must be performed several months later. In many endemic regions, people live far from referral centres which entails that a large proportion of infants rarely go back for diagnosis confirmation and treatment, if infected. Consequently, they evolve to the chronic phase of the disease with the risk of developing severe manifestations.

Molecular-based diagnostics have a very high sensitivity to detect congenital T. cruzi infections, but laboratories in those distant regions are not equipped to perform them. With the aim to provide a suitable point-of-care (POC) test for the timely diagnosis of congenital Chagas disease in these settings, we will validate the implementation of EIKEN T. cruzi loop-mediated isothermal amplification (LAMP) prototype in the field.

Total Funding

¥ 147,127,368

Our Team

Coordinator

ISGlobal Team

Veure més

Altres projectes

Veure projectes passats

NHEPACHA

Noves Eines per al Diagnòstic i l'Avaluació del Pacient amb Malaltia de Chagas

Euroleish.net

Control of Leishmaniasis. From bench to bedside and community

GREPIMER

Grup de recerca en patología importada i malaties emergents i re-emergents

TcONTROL

Biomarcadores inmunológicos antígeno-específicos (células T) asociados al control de la infección por T. cruzi

XStrategy

Modelo y Herramienta para la construcción de estrategias para el incremento de la atención en Chagas

STOP

Towards the interruption of transmission of soil-transmitted helminths

TESEO

Nuevos regímenes de quimioterapia y biomarcadores para la enfermedad de Chagas

AVATAR

Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.

ECO

Enhanced and equitable coverage of COVID-19 testing and treatment in Bolivia and Paraguay